Transdermal Drug Delivery Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, Japan - Size and Forecast 2024-2028
| Published: Nov 2023 | Pages: 168 | SKU: IRTNTR76784 |
Transdermal Drug Delivery Market 2024-2028
The Global Transdermal Drug Delivery Market size is estimated to grow by USD 2.44 billion at a CAGR of 4.9% between 2023 and 2028.
There has been an increasing application of transdermal patches across the world. For instance, transdermal patches are widely used for managing chronic pain conditions. In addition, they offer a controlled release of analgesics directly through the skin, providing continuous pain relief for conditions such as arthritis, back pain, or neuropathic pain. Moreover, transdermal patches containing medications such as scopolamine are used to prevent motion sickness, while antiemetic patches are applied to manage nausea. Hence, such applications are positively impacting the market growth.
Technavio has segmented the market into Application, Type, and Geography
- The application segment is classified into analgesics, neurological disorders, hormone replacement therapy, cardiovascular disorders, and others
- The type segment is classified into transdermal patches and transdermal semisolids
- The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
What will be the Size of the Transdermal Drug Delivery Market During the Forecast Period?
To learn more about this report, Request Free Sample
Transdermal Drug Delivery Market Segmentation by Application, Type, and Geography Analysis
Application Analysis
Analgesics
The analgesics segment is estimated to witness significant growth during the forecast period. Analgesics segment refers to medications that relieve pain by changing the ability to sense the surroundings or alter consciousness and are sometimes called painkillers. Furthermore, these medications help to relieve different types of pain, including headaches and injuries to arthritis.
Get a glance at the market contribution of various segments Download PDF Sample
The analgesics segment was the largest segment and was valued at USD 2.66 billion in 2018. Moreover, some analgesics can be bought over the counter, and others might require an appropriate prescription. In addition, there are several types of analgesics, such as anti-inflammatory analgesics, which reduce inflammation, and opioid analgesics, which change the way the brain perceives pain. Furthermore, the demand for analgesics is increasing as the trend of using analgesics as a pain relief patch in the form of non-invasive delivery of medications through the skin surface is gaining popularity. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
Type Analysis
Transdermal patches
The transdermal patch segment refers to a patch that contains medication and attaches to the skin. In addition, the transdermal patch is seen as a comfortable option for taking some medications when compared to having a pill or an injection. Moreover, transdermal patches are easy to use, and the appropriate usage of the transdermal patches delivers a range of drugs into the body. In addition, some of the drugs that are most often used in transdermal patches include fentanyl to relieve pain, nicotine to help with quitting smoking, and clonidine to treat high blood pressure. Furthermore, with the increase in the number of smokers globally, the usage of nicotine transdermal skin patches coupled with the increasing number of patients is fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
Transdermal semisolids
Transdermal semisolids, including gels, creams, and ointments, have been gaining traction in the field of transdermal drug delivery. In addition, semisolid formulations can be engineered to improve skin penetration, allowing drugs to pass through the skin's layers more effectively. Moreover, gels, creams, and ointments are easy to apply and spread over the skin, providing patient convenience. In addition, compared to certain other delivery methods, semisolids can be gentler on the skin, reducing the potential for irritation or allergic reactions. As a result, these advantages have led to increased interest and research in developing transdermal semisolid formulations for various medications which is fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Regional Analysis
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 55% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors that are fuelling the growth of the market in North America include the rising prevalence of targeted diseases, including chronic pain, central nervous system disorders, and cardiovascular diseases in the region, coupled with the growing use of contraceptives and the increasing number of research activities related to transdermal drug delivery systems.
In addition, the rise in the geriatric population in the region increases the demand for geriatric medicines as the transdermal drug delivery systems help deliver drugs in a controlled manner, hence increasing the effectiveness of geriatric medicines. Hence, such factors are driving the market growth in North America during the forecast period.
Key Transdermal Drug Delivery Market Players
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market companies, including:
Boehringer Ingelheim International GmbH: The company offers transdermal drug delivery solution namely Catapres TTS.
- 3M Co.
- Croda International Plc
- Hisamitsu Pharmaceutical Co. Inc.
- Johnson and Johnson
- Kindeva Drug Delivery L.P.
- Luye Pharma Group Ltd.
- Medherant Ltd.
- Novartis AG
- ProSolus Inc.
- Purdue Pharma LP
- Radius Health Inc.
- Rusan Pharma Ltd.
- Sparsha Pharma International Pvt. Ltd.
- Teikoku Seiyaku Co. Ltd.
- UCB SA
- Viatris Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Transdermal Drug Delivery Market: Key Drivers, Trends, Challenges, and Customer Landscape
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
Key Transdermal Drug Delivery Market Drivers
One of the key factors driving the transdermal drug delivery market growth is the biodegradable and biocompatible materials for transdermal drug delivery. There are several advantages to the use of biodegradable and biocompatible materials in transdermal drug delivery systems such as safety, reduced environmental impact, and improved patient acceptance. In addition, biodegradable hydrogels, such as those based on polyethylene glycol (PEG) or natural polymers, including hyaluronic acid or dextran, are used to create matrices for controlled drug release through the skin.
Moreover, these hydrogels offer high water content and good biocompatibility. In addition, nitrocellulose, derived from plant-based sources, is an emerging biodegradable material used for drug delivery systems due to its biocompatibility, high surface area, and tunable properties. Moreover, these materials offer good biocompatibility and have been used in formulations for controlled drug release. Hence, such factors are driving the market growth during the forecast period.
Significant Transdermal Drug Delivery Market Trends
A key factor shaping the transdermal drug delivery market growth is the robust demand for non-invasive treatment. There is an increasing preference by patients for non-invasive treatments due to reduced pain, minimal discomfort, and quicker recovery times compared with invasive procedures. In addition, this preference contributes significantly to the demand for non-invasive options. Furthermore, non-invasive treatments generally carry lower risks of complications, infections, and adverse reactions compared with invasive surgeries or procedures.
Moreover, this aspect attracts individuals seeking safer treatment alternatives. Innovations in medical technology have expanded the availability and efficacy of non-invasive treatments. In addition, technologies such as lasers, ultrasound, radiofrequency, and transdermal drug delivery systems offer effective alternatives to invasive procedures. Furthermore, non-invasive treatments often involve minimal or no downtime, allowing individuals to resume their daily activities immediately or shortly after the procedure. Hence, such factors are driving the market growth during the forecast period.
Major Transdermal Drug Delivery Market Challenges
Skin irritation and allergic reactions associated with transdermal drug delivery are the key challenges hindering the transdermal drug delivery market growth. Some of the side effects of transdermal patches include skin irritation or allergic reactions at the application site affecting patient comfort and adherence. In addition, ingredients used in the adhesive, matrix, or backing of the transdermal patch can trigger skin reactions.
Moreover, adhesives, or substances in the patch formulation might cause irritation or allergic responses in certain individuals. In addition, continuous or repeated use of patches on the same area of the skin might lead to localized skin irritation, redness, or discomfort. Furthermore, failure to properly clean and dry the application site before placing the patch also contributes to skin irritation or reactions. Hence, such factors are hindering the market growth during the forecast period.
Key Transdermal Drug Delivery Market Customer Landscape
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Transdermal Drug Delivery Market Customer Landscape
Segment Overview
The transdermal drug delivery market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
- Application Outlook
- Analgesics
- Neurological disorders
- Hormone replacement therapy
- Cardiovascular disorders
- Others
- Type Outlook
- Transdermal patches
- Transdermal semisolids
- Geography Outlook
- North America
- The U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Rest of the World (ROW)
- Australia
- Argentina
- Brazil
- North America
|
Transdermal Drug Delivery Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.9% |
|
Market Growth 2024-2028 |
USD 2.44 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.44 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 55% |
|
Key countries |
US, Germany, France, UK, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
What are the Key Data Covered in this Transdermal Drug Delivery Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the transdermal drug delivery market between 2024 and 2028
- Precise estimation of the transdermal drug delivery market size and its contribution to the market in focus on the parent market
- Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
- Companies landscape comparing criticality of inputs and factors of differentiation
- Exclusive Matrix on companies position and classification
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of transdermal drug delivery market companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global transdermal drug delivery market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
- 4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
- 4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Analgesics - Market size and forecast 2023-2028
- Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
- 6.4 Neurological disorders - Market size and forecast 2023-2028
- Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
- 6.5 Hormone replacement therapy - Market size and forecast 2023-2028
- Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
- 6.6 Cardiovascular disorders - Market size and forecast 2023-2028
- Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
- 6.7 Others - Market size and forecast 2023-2028
- Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.8 Market opportunity by Application
- Exhibit 54: Market opportunity by Application ($ billion)
- Exhibit 55: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Type
- 7.1 Market segments
- Exhibit 56: Chart on Type - Market share 2023-2028 (%)
- Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Exhibit 58: Chart on Comparison by Type
- Exhibit 59: Data Table on Comparison by Type
- 7.3 Transdermal patches - Market size and forecast 2023-2028
- Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
- 7.4 Transdermal semisolids - Market size and forecast 2023-2028
- Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Type
- Exhibit 68: Market opportunity by Type ($ billion)
- Exhibit 69: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.10 France - Market size and forecast 2023-2028
- Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.11 UK - Market size and forecast 2023-2028
- Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 116: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 117: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification
- 12.3 3M Co.
- Exhibit 119: 3M Co. - Overview
- Exhibit 120: 3M Co. - Business segments
- Exhibit 121: 3M Co. - Key news
- Exhibit 122: 3M Co. - Key offerings
- Exhibit 123: 3M Co. - Segment focus
- 12.4 Boehringer Ingelheim International GmbH
- Exhibit 124: Boehringer Ingelheim International GmbH - Overview
- Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 126: Boehringer Ingelheim International GmbH - Key news
- Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
- 12.5 Croda International Plc
- Exhibit 129: Croda International Plc - Overview
- Exhibit 130: Croda International Plc - Business segments
- Exhibit 131: Croda International Plc - Key news
- Exhibit 132: Croda International Plc - Key offerings
- Exhibit 133: Croda International Plc - Segment focus
- 12.6 Hisamitsu Pharmaceutical Co. Inc.
- Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
- Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
- Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
- 12.7 Johnson and Johnson
- Exhibit 137: Johnson and Johnson - Overview
- Exhibit 138: Johnson and Johnson - Business segments
- Exhibit 139: Johnson and Johnson - Key news
- Exhibit 140: Johnson and Johnson - Key offerings
- Exhibit 141: Johnson and Johnson - Segment focus
- 12.8 Kindeva Drug Delivery L.P.
- Exhibit 142: Kindeva Drug Delivery L.P. - Overview
- Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service
- Exhibit 144: Kindeva Drug Delivery L.P. - Key news
- Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings
- 12.9 Luye Pharma Group Ltd.
- Exhibit 146: Luye Pharma Group Ltd. - Overview
- Exhibit 147: Luye Pharma Group Ltd. - Business segments
- Exhibit 148: Luye Pharma Group Ltd. - Key offerings
- Exhibit 149: Luye Pharma Group Ltd. - Segment focus
- 12.10 Medherant Ltd.
- Exhibit 150: Medherant Ltd. - Overview
- Exhibit 151: Medherant Ltd. - Product / Service
- Exhibit 152: Medherant Ltd. - Key offerings
- 12.11 Novartis AG
- Exhibit 153: Novartis AG - Overview
- Exhibit 154: Novartis AG - Business segments
- Exhibit 155: Novartis AG - Key offerings
- Exhibit 156: Novartis AG - Segment focus
- 12.12 ProSolus Inc.
- Exhibit 157: ProSolus Inc. - Overview
- Exhibit 158: ProSolus Inc. - Product / Service
- Exhibit 159: ProSolus Inc. - Key offerings
- 12.13 Purdue Pharma LP
- Exhibit 160: Purdue Pharma LP - Overview
- Exhibit 161: Purdue Pharma LP - Product / Service
- Exhibit 162: Purdue Pharma LP - Key offerings
- 12.14 Radius Health Inc.
- Exhibit 163: Radius Health Inc. - Overview
- Exhibit 164: Radius Health Inc. - Product / Service
- Exhibit 165: Radius Health Inc. - Key offerings
- 12.15 Teikoku Seiyaku Co. Ltd.
- Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview
- Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service
- Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings
- 12.16 UCB SA
- Exhibit 169: UCB SA - Overview
- Exhibit 170: UCB SA - Product / Service
- Exhibit 171: UCB SA - Key offerings
- 12.17 Viatris Inc.
- Exhibit 172: Viatris Inc. - Overview
- Exhibit 173: Viatris Inc. - Business segments
- Exhibit 174: Viatris Inc. - Key news
- Exhibit 175: Viatris Inc. - Key offerings
- Exhibit 176: Viatris Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 179: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources
- 13.5 List of abbreviations
- Exhibit 183: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
transdermal drug delivery market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis